Polaris Genomics

company

About

Harnessing genomics, we make invisible wounds like PTSD visible.

  • 11 - 50

Details

Last Funding Type
Non-Equity Assistant
Industries
Biotechnology,Clinical Trials,Health Diagnostics,Life Science,Pharmaceutical
Founded date
Jan 1, 2017
Number Of Employee
11 - 50
Operating Status
Active

At the junction of precision medicine and behavioral health, our vision is to reduce suicide, stigma, and suffering in silence. Our products and services include:

- PTS-ID is a genomics test that provides objective information to help clinicians confidently and quickly assess patients with cortisol dysregulation associated with PTSD. Results of the test can be combined with behavioral risk survey data to give clinicians a whole-picture view of the patient’s state, enabling earlier, more targeted PTSD treatment.
Polaris’ TruNorth Platform provides comprehensive utilization of integrated data sources that creates a complete picture of patient health and PTSD risk.

TruGen-1 is a 1003-gene panel that supports genomic research across a spectrum of neuropsychiatric conditions.

Endeavor Lab is a nimble high-complexity CLIA lab that offers a wide variety of genomic sequencing, analysis, and lab testing services, including next-generation sequencing, CLIA / CAP clinical genetic testing, and assay processing, ushering a more in-depth understanding of neuropsychiatric conditions, and enabling the development of - and access to - precision diagnostics.

PTSD diagnostics and pandemic era Covid-19 testing are in this company’s DNA, but Polaris is also well versed in immunology and virology, and fluent in leveraging the power of genomics and machine learning.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$200K
Polaris Genomics has raised a total of $200K in funding over 2 rounds. Their latest funding was raised on Jul 24, 2020 from a Non-Equity Assistant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jul 24, 2020 Non-Equity Assistant 1 Google for Startups Detail
Dec 18, 2018 Grant $200K 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
2
Polaris Genomics is funded by 2 investors. Google for Startups and George Shultz Innovation Fund are the most recent investors.
Investor Name Lead Investor Funding Round
Google for Startups Yes Non-Equity Assistant
George Shultz Innovation Fund Grant